Could I borrow your phone, please? jobs pressure same dayloan stayed ties Morningstar analyst Michael Waterhouse said Teva shares werelittle affected by the unfavorable court ruling because manyanalysts and investors had already assumed that Copaxone, whichhad sales of $4 billion last year, would face competition fromat least one generic in 2014.